Panbio subsidiary wins US defence department grant
Thursday, 16 February, 2006
Panbio's (ASX:PBO) US subsidiary Panbio Inc has been awarded almost US$100,000 (AUD$135,000) in funding from the US Deparment of Defence.
The Phase I Small Business Innovation Research grant will fund the development of a multiplex assay for agents of infectious disease based on Panbio's patented Oligo Rapid lateral flow technology which will enable testing for multiple disease states from a single disposable device.
If Maryland-based Panbio Inc successfully completes the research for the grant, the company can bid for a Phase 2 grant, valued up to US$750,000.
Farm animals and aquaculture cryopreservation partnership announced
Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
